logo

NHTC

Natural Health Trends·NASDAQ
--
--(--)
--
--(--)
1.28 / 10
Underperform

Fundamentally the stock scores 1.3/10, flagged as Underperform. Operating cycle and cash‑flow‑to‑revenue are modest positives, while negative net profit margin, high current‑liabilities ratio and weak ROE drag performance, indicating constrained upside.

Fundamental(1.28)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value0.14
Score2/3
Weight2.24%
1M Return-0.62%
Shareholders’ equity attributable to parent company / Total liabilities (%)
Value1.56
Score3/3
Weight-10.57%
1M Return2.25%
Operating cycle
Value90.98
Score3/3
Weight-8.92%
1M Return1.86%
Net cash flow from operating activities / Operating revenue (%)
Value-15.08
Score2/3
Weight9.41%
1M Return-2.30%
Current liabilities / Total liabilities (%)
Value91.26
Score0/3
Weight22.32%
1M Return-8.17%
Net profit margin (%)
Value-2.22
Score1/3
Weight14.97%
1M Return-4.38%
ROE (diluted) (%)
Value-3.76
Score2/3
Weight7.95%
1M Return-2.37%
Net profit / Total operating revenue (%)
Value-2.22
Score1/3
Weight14.97%
1M Return-4.38%
Asset-MV
Value-0.55
Score1/3
Weight24.55%
1M Return-9.39%
Cash-MV
Value0.02
Score0/3
Weight23.07%
1M Return-8.15%
Is NHTC undervalued or overvalued?
  • NHTC scores 1.28/10 on fundamentals and holds a Premium valuation at present. Backed by its -3.13% ROE, -2.22% net margin, -27.43 P/E ratio, 1.03 P/B ratio, and -260.00% earnings growth, these metrics solidify its Underperform investment rating.